Quantumscape Corp vs Vital Farms Inc — how do they compare? Quantumscape Corp trades at $4.57 (market cap $2.82B), while Vital Farms Inc trades at $9.33 (market cap $405.27M). The key difference: Quantumscape Corp is far larger — about 7× Vital Farms Inc's market cap, and Quantumscape Corp is more actively traded (21,878,246 versus 1,810,837). Which is the better fit depends on your goals — on Pluang, investors hold Quantumscape Corp for 37 Days and Vital Farms Inc for 14 Days on average.
| QS | VITL | |
|---|---|---|
Market Cap | $2.82B | $405.27M |
Volume | 21,878,246 | 1,810,837 |
Sector | Consumer Cyclical | Consumer Staples |
52-Week High | $18.44 | $43.68 |
52-Week Low | $4.52 | $8.28 |
Typical Hold Time | 37 Days | 14 Days |
Enterprise Value | $2.03B | $492.28M |
Signals from Pluang's Aura AI — not financial advice
QuantumScape (QS) trades at $4.52, down 2.8% on the day, reflecting ongoing investor skepticism about the solid-state battery developer's path to commercialization. The stock shows bearish technical signals with negative moving averages and oscillators, while fundamental challenges persist with zero revenue, negative EBITDA of -$358.25M (2025), and consecutive quarterly losses. Recent news highlights commercialization delays and insider selling, though the company continues ramping pilot production lines for automotive and new market applications.
The outlook remains high-risk with commercialization not expected until 2029, creating significant execution and competitive threats. While the consensus price target of $10.35 suggests potential upside from current levels, analyst sentiment is cautious with 73% hold ratings. Investment opportunity exists only for speculative investors comfortable with pre-revenue developmental stage risks and extended timelines to profitability.
Vital Farms (VITL) trades at $9.24, down 1.7% on the day, reflecting ongoing pressure from weak earnings and industry headwinds. The stock shows a bearish technical trend with key support at $9.00, while fundamentals reveal a sharp decline in profitability with a net margin of just 0.02% in 2026. Recent news highlights strategic review discussions and institutional acquisitions, yet negative cash flow and pricing challenges in the egg market weigh on investor confidence.
The outlook remains cautious with significant execution risks amid industry oversupply, though analyst consensus suggests upside potential to a $13.11 price target. Investment opportunity hinges on a successful strategic review and margin recovery, but risks include sustained cash burn and competitive pressures that could limit near-term gains.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →